| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 114 companies in the Pharmaceuticals industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2021 | CPIX Cumberland Pharmaceuticals Inc | Young Caroline52 | Director | Buy | 345 | $3.04 | $1,048.50 | +0.1% | -4.0% | -27.1% | |
| Jun 30, 2021 | CPIX Cumberland Pharmaceuticals Inc | Kazimi A J59 | Chairman And CEO | Buy | 345 | $3.04 | $1,048.50 | - | -4.0% | -27.1% | |
| Jun 29, 2021 | UTHR United Therapeutics Corp | Dwek Raymond | Director | Sell | 3,360 | $176.01 | $591,393.60 | -100% | +10.3% | +34.6% | |
| Jun 29, 2021 | CPIX Cumberland Pharmaceuticals Inc | Cearnal Martin E47 | Sr Vp/ Chief Commercial Officer | Buy | 3,150 | $3.01 | $9,495.15 | - | -6.2% | -29.6% | |
| Jun 28, 2021 | TAK Takeda Pharmaceutical Co Ltd | Takeda Pharmaceutical Co Ltd70 | 10% Owner | Sell | 24,501 | $35.49 | $869,427.36 | -0.9% | +0.7% | -14.5% | |
| Jun 25, 2021 | BTAI Bioxcel Therapeutics, Inc. | Nandabalan Krishnan75 | Director | Sell | 473,250 | $30.83 | $14,589,492.98 | -5.2% | +3.1% | -61.0% | |
| Jun 25, 2021 | BTAI Bioxcel Therapeutics, Inc. | Mehta Vimal92 | CEO, President And Secretary | Sell | 473,250 | $30.83 | $14,589,492.98 | -5.2% | +3.1% | -61.0% | |
| Jun 25, 2021 | BTAI Bioxcel Therapeutics, Inc. | Bioxcel Holdings, Inc. | 10% Owner | Sell | 473,250 | $30.83 | $14,589,492.98 | -5.2% | +3.1% | -61.0% | |
| Jun 25, 2021 | BTAI Bioxcel Therapeutics, Inc. | Bioxcel LLC | 10% Owner | Sell | 473,250 | $30.83 | $14,589,492.98 | -5.2% | +3.1% | -61.0% | |
| Jun 24, 2021 | LLY Eli Lilly & Co | Lilly Endowment Inc | 10% Owner | Sell | 12,898 | $237.51 | $3,063,400.51 | - | -1.7% | +41.7% | |
| Jun 24, 2021 | TAK Takeda Pharmaceutical Co Ltd | Takeda Pharmaceutical Co Ltd70 | 10% Owner | Sell | 11,048 | $35.14 | $388,198.72 | -0.6% | +0.7% | -14.6% | |
| Jun 22, 2021 | TAK Takeda Pharmaceutical Co Ltd | Takeda Pharmaceutical Co Ltd70 | 10% Owner | Sell | 9,394 | $35.31 | $331,671.14 | -0.5% | +1.2% | -15.7% | |
| Jun 21, 2021 | BUDZ Weed, Inc. | Breen Nicole M | Secretary/ Treasurer | Sell | 25,000 | $0.44 | $11,000.00 | - | - | - | |
| Jun 18, 2021 | HROW Harrow, Inc. | Opaleye Management Inc.60 | - | Buy | 74,584 | $8.34 | $622,389.01 | +1.2% | +10.3% | -21.4% | |
| Jun 18, 2021 | TLRY Tilray Brands, Inc. | Kennedy Brendan87 | Director | Sell | 800,000 | $17.58 | $14,060,680.00 | -4.1% | -29.0% | -81.1% | |
| Jun 18, 2021 | TAK Takeda Pharmaceutical Co Ltd | Takeda Pharmaceutical Co Ltd70 | 10% Owner | Sell | 8,703 | $35.11 | $305,571.14 | -0.5% | +3.9% | -17.4% | |
| Jun 18, 2021 | HIMS Hims & Hers Health, Inc. | Baird Melissa | Chief Operating Officer | Sell | 41,076 | $10.91 | $448,214.77 | -8.5% | -22.4% | -60.8% | |
| Jun 18, 2021 | HIMS Hims & Hers Health, Inc. | Lee Spencer | Chief Financial Officer | Sell | 57,752 | $10.92 | $630,533.02 | -39.7% | -22.4% | -60.8% | |
| Jun 18, 2021 | HIMS Hims & Hers Health, Inc. | Carroll Patrick Harrison52 | Chief Medical Officer | Sell | 3,938 | $11.08 | $43,650.96 | -16.2% | -22.4% | -60.8% | |
| Jun 18, 2021 | HIMS Hims & Hers Health, Inc. | Boughton Soleil | Chief Legal Officer | Sell | 6,757 | $11.42 | $77,135.71 | -0.9% | -22.4% | -60.8% | |
| Jun 18, 2021 | HIMS Hims & Hers Health, Inc. | Dudum Andrew48 | Chief Executive Officer | Sell | 218,695 | $10.71 | $2,342,853.62 | -38.1% | -22.4% | -60.8% | |
| Jun 16, 2021 | LNTH Lantheus Holdings, Inc. | Bolla John J. | Chief Operations Officer | Sell | 2,253 | $24.37 | $54,912.37 | -2.2% | -0.3% | +141.4% | |
| Jun 15, 2021 | TCNNF Trulieve Cannabis Corp. | Rivers Kim A. | President And CEO | Buy | 29,000 | $35.94 | $1,042,149.80 | +59.3% | - | - | |
| Jun 15, 2021 | ETON Eton Pharmaceuticals, Inc. | Opaleye Management Inc.60 | - | Sell | 105,000 | $8.07 | $847,350.00 | -2.8% | -25.8% | -57.0% | |
| Jun 14, 2021 | TAK Takeda Pharmaceutical Co Ltd | Takeda Pharmaceutical Co Ltd70 | 10% Owner | Sell | 2,826 | $35.06 | $99,079.56 | -0.3% | -0.9% | -19.5% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.